Education Center

 

QCS Session #9 - Panel Discussion

 

 


 

QCS Session #8 - Sterility Assurance using Sterile Compounding Automation and Technology

 

 


 

QCS Session #7 - API or Approved Product: Where do we start with veterinary compounds?

 

 


 

QCS Session #6 - Cleanroom Certification - Digging Deeper

 

 


 

QCS Session #5 - Root Cause of Stability Failures

 

 


 

QCS Session #4 - Regulatory and Quality Considerations in the Selection of API

 

 


 

QCS Session #3 - Quality Compounding and Clinical Pharmaceutics

 

 


 

QCS Session #2 - Pharmacist/Provider/Patient Triad: A Multidisciplinary Approach to Patient Care

 

 


 

QCS Session #1 -NABP Implementation of the FDA Compounding MOU

 

 


 

Raw Material Revealed

 

 


 

 

A Pharmacist’s Prescription for Bringing in New Customers

 

 


Insurance Considerations for Pharmacists and Professional Liability in Compounding

 

Webinar Q&A

 


COVID-19 Testing and Therapeutics

 


Minor Chapters Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice


More than Selling Compounds

Webinar Q&A


Rapid Sterility Testing Strategies for Compounded Sterile Preparations

Webinar Q&A


Stability Testing: Science and Compliance


Discover New Business Opportunities for Your Pharmacy

Webinar Q&A


Rapid Sterility Testing

Webinar Q&A


USP 800 Update – What is the current status and how do pharmacists proceed?

Webinar Q&A


Beyond Use Date Strategies for Compounded Sterile Preparations


USP General Chapters and Compounded Monograph Chapters: Best Practices and Regulatory Guidance

Webinar Q&A


 

Medical Marijuana (THC and CBD) Pharmacology, Regulation, and Pharmacy Considerations


 

The Practical Use of the USP as a Primary Reference Resource in Compounded Formulations


 

Stability Studies: The Architecture Behind Establishing a Beyond-Use-Date


 

Compounded Sterile Products: Extending Beyond Use Dating and Batch Release Testing for 503A and 503B Facilities


 

An Inside Look at USP <71>


 

USP <800> and Environmental Monitoring Requirements


 

Stability Indicating Methods


 

Extending Beyond Use Dating for Compounding Preparations


 

Microbiology Testing: USP Requirements for Sterile and Non-Sterile Preparations

 

 

​​​​​

Click here to view Articles